4 résultats
Second-line therapy in elderly patients with advanced non-small cell lung carcinoma: analysis of the IFCT-0501 Phase III study comparing single-agent therapy to carboplatin-based doublet therapy with fixed second-line erlotinib therapy.
Auteurs / Authors
Quoix E, Westeel V, Moreau L, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Sennelart H, Tredaniel J, Mennecier B, Morin F, Baudrin L, Milleron B, Zalcman G; on behalf of Intergroupe Francophone de CancérologieThoracique
Journal / Conference
European Respiratory Journal
Année / Year
2014
PMID / session
Etude IFCT
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
Auteurs / Authors
Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducoloné A, Lebitasy MP, Baudrin L, Laporte S, Milleron B; Intergroupe Francophone de Cancérologie Thoracique
Journal / Conference
The Lancet
Année / Year
2011
PMID / session
Etude IFCT
Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over
Auteurs / Authors
Quoix E, Ducoloné A, Mennecier B, Fraisse P
Journal / Conference
Presse Médicale
Année / Year
2011
PMID / session
Etude IFCT
Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC)
Auteurs / Authors
E. A. Quoix , J. Oster , V. Westeel , E. Pichon , G. Zalcman , L. BaudrinA. Lavole , J. Dauba , M. Lebitasy , B. J. Milleron , on behalf of IFCT
Journal / Conference
ASCO
Année / Year
2010
PMID / session
Etude IFCT